Pseudomonas aeruginosa Outer Membrane Vesicles Modulate Host Immune Responses by Targeting the Toll-Like Receptor 4 Signaling Pathway (vol 81, pg 4509, 2013)

被引：0
|
作者：
Zhao, Kelei [1 ,2 ]
Deng, Xin [3 ,4 ]
He, Chuan [3 ,4 ]
Yue, Bisong [2 ]
Wu, Min [1 ]
机构：
[1] Univ N Dakota, Dept Biochem & Mol Biol, Sch Med & Hlth Sci, Grand Forks, ND 58201 USA
[2] Sichuan Univ, Coll Life Sci, Minist Educ, Key Lab Bioresources & Ecoenvironm, Chengdu 610064, Sichuan, Peoples R China
[3] Univ Chicago, Dept Chem, Chicago, IL 60637 USA
[4] Univ Chicago, Inst Biophys Dynam, Chicago, IL 60637 USA
来源：
INFECTION AND IMMUNITY | 2015年 / 83卷 / 05期
关键词：
D O I：
10.1128/IAI.00211-15
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：2198 / 2198
页数：1
相关论文
共 50 条
  • [41] Toll-like receptor-4 differentially mediates intestinal and extra-intestinal immune responses upon multi-drug resistant Pseudomonas aeruginosa association of IL10−/− mice with chronic colitis
    Anne Grunau
    Ulrike Escher
    Anja A. Kühl
    Stefan Bereswill
    Markus M. Heimesaat
    Gut Pathogens, 9
  • [42] Phospholipid flippases attenuate LPS-induced TLR4 signaling by mediating endocytic retrieval of Toll-like receptor 4 (vol 74, pg 715, 2017)
    van der Mark, Vincent A.
    Ghiboub, Mohammed
    Marsman, Casper
    Zhao, Jing
    van Dijk, Remco
    Hiralall, Johan K.
    Ho-Mok, Kam S.
    Castricum, Zoe
    de Jonge, Wouter J.
    Oude Elferink, Ronald P. J.
    Paulusma, Coen C.
    CELLULAR AND MOLECULAR LIFE SCIENCES, 2017, 74 (07) : 1365 - 1365
  • [43] Endocytosed HSP60s use toll-like receptor 2 (TLR2) and TLR4 to activate the Toll/interleukin-1 receptor signaling pathway in innate immune cells
    Vabulas, RM
    Ahmad-Nejad, P
    da Costa, C
    Miethke, T
    Kirschning, CJ
    Häcker, H
    Wagner, H
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (33) : 31332 - 31339
  • [44] The p38 mitogen-activated protein kinase signaling pathway is coupled to toll-like receptor 5 to mediate gene regulation in response to Pseudomonas aeruginosa infection in human airway epithelial cells
    Zhang, Zhe
    Reenstra, William
    Weiner, Daniel J.
    Louboutin, Jean-Pierre
    Wilson, James M.
    INFECTION AND IMMUNITY, 2007, 75 (12) : 5985 - 5992
  • [45] RETRACTION: Vitamin D3 alters Toll-like receptor 4 signaling in monocytes of pregnant women at risk for preeclampsia (Retraction of Vol 8, Pg 18041, 2015)
    Qian, L.
    Wang, H. Y.
    Wu, F. H.
    Li, M.
    Chen, W.
    Lv, L. Z.
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2018, 11 (08): : 8801 - 8801
  • [46] Timing of Toll-Like Receptor 9 Agonist Administration in Pneumococcal Vaccination Impacts Both Humoral and Cellular Immune Responses as Well as Nasopharyngeal Colonization in Mice (vol 80, pg 1744, 2012)
    Jensen, Katrine M.
    Melchjorsen, Jesper
    Dagnaes-Hansen, Frederik
    Sorensen, Uffe B. S.
    Laursen, Rune R.
    Ostergaard, Lars
    Sogaard, Ole S.
    Tolstrup, Martin
    INFECTION AND IMMUNITY, 2014, 82 (09) : 3987 - 3987
  • [47] Glycogen synthase kinase 3β and β-catenin pathway is involved in toll-like receptor 4-mediated NADPH oxidase 1 expression in macrophages (vol 277, pg 2830, 2010)
    Kim, J-S
    FEBS JOURNAL, 2010, 277 (15) : 3264 - 3264
  • [48] Regulatory B cells induced by ultraviolet B through toll-like receptor 4 signalling contribute to the suppression of contact hypersensitivity responses in mice (vol 78, pg 117, 2018)
    Liu, X.
    Huang, H.
    Gao, H.
    CONTACT DERMATITIS, 2024, 90 (03) : 329 - 329
  • [49] RETRACTION: MiR-145 Regulates the Chemoresistance of Hepatic Carcinoma Cells Against 5-Fluorouracil by Targeting Toll-Like Receptor 4 (Retraction of Vol 12, Pg 6165, 2020)
    Zheng, R. P.
    Ma, D. K.
    Li, Z.
    Zhang, H. F.
    CANCER MANAGEMENT AND RESEARCH, 2023, 15 : 1013 - 1013
  • [50] MiR-145 Regulates the Chemoresistance of Hepatic Carcinoma Cells Against 5-Fluorouracil by Targeting Toll-Like Receptor 4 (Expression of Concern of Vol 12, Pg 6165, 2020)
    Zheng, R. P.
    Ma, D. K.
    Li, Z.
    Zhang, H. F.
    CANCER MANAGEMENT AND RESEARCH, 2022, 14 : 387 - 387
12345